Centiva Capital, LP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
Centiva Capital, LP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$303,050
-91.9%
2,500
-91.3%
0.01%
-86.8%
Q4 2022$3,739,678
+333.8%
28,860
+270.0%
0.05%
+211.8%
Q3 2022$862,000
+318.4%
7,800
+508.4%
0.02%
+41.7%
Q2 2020$206,000
-55.8%
1,282
-79.3%
0.01%
-57.1%
Q3 2019$466,0006,1840.03%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders